HALT Fentanyl Act

Expedited Research Procedures: Practitioners can conduct research more quickly by sending a notice to the Attorney General instead of undergoing a standard registration process, provided they meet specific criteria (Section 3).

Simplified Institutional Research: Agents or employees of a research institution can perform research under the registration of another employee within the same institution, which may streamline institutional workflows (Section 3).

Streamlined Multi-Site Research: Researchers can conduct studies across multiple sites under a single registration if the sites are within the same city or county and under the same institutional control (Section 3).

Reduced Inspection Burdens: A new inspection of a registered location is not required when a person applies to conduct research with a second controlled substance in the same or a higher schedule (Section 3).

Continued Research Stability: If a substance is newly added to Schedule I, those already conducting research on it can continue their work while their application for modification is processed (Section 3).

Simplified Manufacturing for Research: Researchers can perform certain manufacturing activities, such as creating extracts or solutions, without needing a separate manufacturing registration (Section 3).

Increased Criminal Penalties: The bill expands the scope of penalties regarding the manufacture and distribution of controlled substances to include fentanyl-related substances (Section 6).

Increased Import/Export Restrictions: Fentanyl-related substances are now included in the scope of the Controlled Substances Import and Export Act (Section 6).

Strict Possession Limits: Practitioners conducting research under the expedited procedures are limited to possessing only the specific amounts identified in their notification or supplemental notification (Section 3).